The Sydney Project aims to have human embryonic stem cells in clinical trials to treat type 1 diabetes in four years.

Geron scientists and collaborators differentiate human embryonic stem cells into insulin-producing islet-like clusters.

The 11th International Congress on Human Genetics has secured a world-class line-up, not the least of whom is Elizabeth Blackburn. She's looking forward to returning to her former home to reveal more about the activity of her pet subject, telomerase.

The human embryonic stem (ES) cell field is one of the most exciting and complex opportunities of today's biomedical industry, write Peter Mountford and Kenzo Nakajima.

US biotechnology company Geron has taken a 25 per cent equity position in Austin Research Institute spin-off XenoTrans, in return for granting the company a non-exclusive licence to use Geron's nuclear transfer technology to produce transgenic pigs for xenotransplantation, and a share in future revenues.

Clone International has crossed the Tasman in its search for elite dairy bulls. A joint venture agreement has been signed with NZ artificial breeding company Ambreed New Zealand.